Trump admin. to reportedly drop Medicare GLP-1 plan

3 hours ago 1

Fri, Apr 4, 2025, 2:17 PM

The Trump medication has decided not to backmost a Biden medication program that would person allowed Medicare to wage for obesity drugs, according to a study from Bloomberg. Shares of some Eli Lilly (LLY) and Novo Nordisk (NVO) traded little connected the news. Learn much successful the video above.

To ticker much adept insights and investigation connected the latest marketplace action, cheque retired much Asking for a Trend here.

00:00 Speaker A

All right, well, header conscionable coming crossed successful the past fewer minutes. Bloomberg reporting the Trump medication volition driblet the Biden epoch Medicare obesity cause sum proposal. In precocious November, the Biden medication projected a regularisation that would person made millions of Americans with obesity eligible to person fashionable value nonaccomplishment drugs similar Wegovy oregon Zepbound covered by Medicare oregon Medicaid. Now, according to Bloomberg, the Centers for Medicare and Medicaid Services could reconsider sum of the drugs successful the future, but HHS Secretary Robert Kennedy Jr. is an hostile of value nonaccomplishment drugs, and shares of some Eli Lilly and Novo Nordisk are nether unit successful after-hours trading. Not precisely the headlines those companies wanted to spot aft the week that we've seen successful the markets overall.